IPO centre
30 scheduled or priced listing(s) and 10 recently listed, read from the stored ipo table.
Every figure is the row as filed into this application; nothing is sourced from a wire feed at page load.
DEMO DATASET last stored bar 2026-10-23 · scores computed 2026-10-23 17:35:24 · every figure below is read from these rows, nothing is computed in the browser
Tracked filings15rows with a stored first-day return
Mean day-one return+13.4%
Positive day one10 / 15
Mean intel score66.3the stored 0–100 ranking column
Upcoming and priced
Offer range and valuation as stored on the filing row. “Confidence” is the field the row carries about its own date, not a probability from a model.
| Ticker | Company | Status | Pricing | Days | Listing | Offer range | Mid | Proceeds | Valuation | Lead underwriters | Tier | Confidence | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LUMN | Lumen Optics | PRICED | 2026-11-17 | in 24 days | 2026-11-20 | 17.00 – 19.00 | $18.00 | $1.45B | $4.14B – $5.15B | Goldman Sachs, Morgan Stanley, J.P. Mor… | tier 2 | firm | detail |
| LUMN | Lumen Optics | PRICED | 2026-11-17 | in 24 days | 2026-11-20 | 17.00 – 19.00 | $18.00 | $1.45B | $4.14B – $5.15B | Goldman Sachs, Morgan Stanley, J.P. Mor… | tier 2 | firm | detail |
| LUMN | Lumen Optics | PRICED | 2026-11-17 | in 24 days | 2026-11-20 | 17.00 – 19.00 | $18.00 | $1.45B | $4.14B – $5.15B | Goldman Sachs, Morgan Stanley, J.P. Mor… | tier 2 | firm | detail |
| LUMN | Lumen Optics | PRICED | 2026-11-17 | in 24 days | 2026-11-20 | 17.00 – 19.00 | $18.00 | $1.45B | $4.14B – $5.15B | Goldman Sachs, Morgan Stanley, J.P. Mor… | tier 2 | firm | detail |
| LUMN | Lumen Optics | PRICED | 2026-11-17 | in 24 days | 2026-11-20 | 17.00 – 19.00 | $18.00 | $1.45B | $4.14B – $5.15B | Goldman Sachs, Morgan Stanley, J.P. Mor… | tier 2 | firm | detail |
| NVX | Novexa Robotics | PRICED | 2026-12-01 | in 38 days | 2026-12-04 | 18.00 – 20.00 | $19.00 | $669M | $3.78B – $4.70B | Morgan Stanley, J.P. Morgan, BofA Secur… | tier 2 | expected | detail |
| NVX | Novexa Robotics | PRICED | 2026-12-01 | in 38 days | 2026-12-04 | 18.00 – 20.00 | $19.00 | $669M | $3.78B – $4.70B | Morgan Stanley, J.P. Morgan, BofA Secur… | tier 2 | expected | detail |
| NVX | Novexa Robotics | PRICED | 2026-12-01 | in 38 days | 2026-12-04 | 18.00 – 20.00 | $19.00 | $669M | $3.78B – $4.70B | Morgan Stanley, J.P. Morgan, BofA Secur… | tier 2 | expected | detail |
| NVX | Novexa Robotics | PRICED | 2026-12-01 | in 38 days | 2026-12-04 | 18.00 – 20.00 | $19.00 | $669M | $3.78B – $4.70B | Morgan Stanley, J.P. Morgan, BofA Secur… | tier 2 | expected | detail |
| NVX | Novexa Robotics | PRICED | 2026-12-01 | in 38 days | 2026-12-04 | 18.00 – 20.00 | $19.00 | $669M | $3.78B – $4.70B | Morgan Stanley, J.P. Morgan, BofA Secur… | tier 2 | expected | detail |
| ATLS | Atlas Data Centers | EXPECTED | 2026-12-15 | in 52 days | 2026-12-18 | 24.00 – 27.00 | $25.50 | $1.97B | $13.3B – $16.6B | Morgan Stanley, J.P. Morgan, BofA Secur… | tier 3 | expected | detail |
| ATLS | Atlas Data Centers | EXPECTED | 2026-12-15 | in 52 days | 2026-12-18 | 24.00 – 27.00 | $25.50 | $1.97B | $13.3B – $16.6B | Morgan Stanley, J.P. Morgan, BofA Secur… | tier 3 | expected | detail |
| ATLS | Atlas Data Centers | EXPECTED | 2026-12-15 | in 52 days | 2026-12-18 | 24.00 – 27.00 | $25.50 | $1.97B | $13.3B – $16.6B | Morgan Stanley, J.P. Morgan, BofA Secur… | tier 3 | expected | detail |
| ATLS | Atlas Data Centers | EXPECTED | 2026-12-15 | in 52 days | 2026-12-18 | 24.00 – 27.00 | $25.50 | $1.97B | $13.3B – $16.6B | Morgan Stanley, J.P. Morgan, BofA Secur… | tier 3 | expected | detail |
| ATLS | Atlas Data Centers | EXPECTED | 2026-12-15 | in 52 days | 2026-12-18 | 24.00 – 27.00 | $25.50 | $1.97B | $13.3B – $16.6B | Morgan Stanley, J.P. Morgan, BofA Secur… | tier 3 | expected | detail |
| HEAL | Helios Therapeutics | EXPECTED | 2026-12-29 | in 66 days | 2027-01-01 | 16.00 – 18.00 | $17.00 | $1.21B | $846M – $1.05B | Goldman Sachs, Morgan Stanley, J.P. Mor… | tier 3 | expected | detail |
| HEAL | Helios Therapeutics | EXPECTED | 2026-12-29 | in 66 days | 2027-01-01 | 16.00 – 18.00 | $17.00 | $1.21B | $846M – $1.05B | Goldman Sachs, Morgan Stanley, J.P. Mor… | tier 3 | expected | detail |
| HEAL | Helios Therapeutics | EXPECTED | 2026-12-29 | in 66 days | 2027-01-01 | 16.00 – 18.00 | $17.00 | $1.21B | $846M – $1.05B | Goldman Sachs, Morgan Stanley, J.P. Mor… | tier 3 | expected | detail |
| HEAL | Helios Therapeutics | EXPECTED | 2026-12-29 | in 66 days | 2027-01-01 | 16.00 – 18.00 | $17.00 | $1.21B | $846M – $1.05B | Goldman Sachs, Morgan Stanley, J.P. Mor… | tier 3 | expected | detail |
| HEAL | Helios Therapeutics | EXPECTED | 2026-12-29 | in 66 days | 2027-01-01 | 16.00 – 18.00 | $17.00 | $1.21B | $846M – $1.05B | Goldman Sachs, Morgan Stanley, J.P. Mor… | tier 3 | expected | detail |
| FINO | Finova Pay | FILED | 2027-02-09 | in 108 days | 2027-02-12 | not stored | not stored | $590M | $2.16B – $2.69B | Goldman Sachs, Morgan Stanley, J.P. Mor… | tier 3 | rumored | detail |
| FINO | Finova Pay | FILED | 2027-02-09 | in 108 days | 2027-02-12 | not stored | not stored | $590M | $2.16B – $2.69B | Goldman Sachs, Morgan Stanley, J.P. Mor… | tier 3 | rumored | detail |
| FINO | Finova Pay | FILED | 2027-02-09 | in 108 days | 2027-02-12 | not stored | not stored | $590M | $2.16B – $2.69B | Goldman Sachs, Morgan Stanley, J.P. Mor… | tier 3 | rumored | detail |
| FINO | Finova Pay | FILED | 2027-02-09 | in 108 days | 2027-02-12 | not stored | not stored | $590M | $2.16B – $2.69B | Goldman Sachs, Morgan Stanley, J.P. Mor… | tier 3 | rumored | detail |
| FINO | Finova Pay | FILED | 2027-02-09 | in 108 days | 2027-02-12 | not stored | not stored | $590M | $2.16B – $2.69B | Goldman Sachs, Morgan Stanley, J.P. Mor… | tier 3 | rumored | detail |
| GRID | GridScale Energy | EXPECTED | 2027-05-25 | in 213 days | 2027-05-28 | 14.00 – 16.00 | $15.00 | $1.72B | $3.51B – $4.37B | Morgan Stanley, J.P. Morgan, BofA Secur… | tier 3 | expected | detail |
| GRID | GridScale Energy | EXPECTED | 2027-05-25 | in 213 days | 2027-05-28 | 14.00 – 16.00 | $15.00 | $1.72B | $3.51B – $4.37B | Morgan Stanley, J.P. Morgan, BofA Secur… | tier 3 | expected | detail |
| GRID | GridScale Energy | EXPECTED | 2027-05-25 | in 213 days | 2027-05-28 | 14.00 – 16.00 | $15.00 | $1.72B | $3.51B – $4.37B | Morgan Stanley, J.P. Morgan, BofA Secur… | tier 3 | expected | detail |
| GRID | GridScale Energy | EXPECTED | 2027-05-25 | in 213 days | 2027-05-28 | 14.00 – 16.00 | $15.00 | $1.72B | $3.51B – $4.37B | Morgan Stanley, J.P. Morgan, BofA Secur… | tier 3 | expected | detail |
| GRID | GridScale Energy | EXPECTED | 2027-05-25 | in 213 days | 2027-05-28 | 14.00 – 16.00 | $15.00 | $1.72B | $3.51B – $4.37B | Morgan Stanley, J.P. Morgan, BofA Secur… | tier 3 | expected | detail |
Recently listed
Returns are measured between stored prices: day one is the first trade against the final offer, and the later figures use the row's last stored price.
| Ticker | Company | Listed | Sector | Offer | First trade | Last | Day 1 | 5d | 30d | Since listing | Rev TTM | Growth | Float % | Lockup | Intel | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ORBT | Orbital Freight Systems | 2026-08-21 | industrials | $22.00 | $27.40 | $25.10 | +24.6% | -8.4% | +14.1% | +14.1% | $1.42B | 31.0% | 17.3% | 2027-02-17 | 68.3 | quote |
| ORBT | Orbital Freight Systems | 2026-08-21 | industrials | $22.00 | $27.40 | $25.10 | +24.6% | -8.4% | +14.1% | +14.1% | $1.42B | 31.0% | 17.3% | 2027-02-17 | 68.3 | quote |
| ORBT | Orbital Freight Systems | 2026-08-21 | industrials | $22.00 | $27.40 | $25.10 | +24.6% | -8.4% | +14.1% | +14.1% | $1.42B | 31.0% | 17.3% | 2027-02-17 | 68.3 | quote |
| ORBT | Orbital Freight Systems | 2026-08-21 | industrials | $22.00 | $27.40 | $25.10 | +24.6% | -8.4% | +14.1% | +14.1% | $1.42B | 31.0% | 17.3% | 2027-02-17 | 68.3 | quote |
| ORBT | Orbital Freight Systems | 2026-08-21 | industrials | $22.00 | $27.40 | $25.10 | +24.6% | -8.4% | +14.1% | +14.1% | $1.42B | 31.0% | 17.3% | 2027-02-17 | 68.3 | quote |
| VEGA | Vega Bio Foods | 2026-03-06 | consumer_staples | $12.00 | $10.40 | $11.10 | -13.3% | +6.7% | -7.5% | -7.5% | $128M | 96.0% | 39.7% | 2026-09-02 | 66.8 | quote |
| VEGA | Vega Bio Foods | 2026-03-06 | consumer_staples | $12.00 | $10.40 | $11.10 | -13.3% | +6.7% | -7.5% | -7.5% | $128M | 96.0% | 39.7% | 2026-09-02 | 66.8 | quote |
| VEGA | Vega Bio Foods | 2026-03-06 | consumer_staples | $12.00 | $10.40 | $11.10 | -13.3% | +6.7% | -7.5% | -7.5% | $128M | 96.0% | 39.7% | 2026-09-02 | 66.8 | quote |
| VEGA | Vega Bio Foods | 2026-03-06 | consumer_staples | $12.00 | $10.40 | $11.10 | -13.3% | +6.7% | -7.5% | -7.5% | $128M | 96.0% | 39.7% | 2026-09-02 | 66.8 | quote |
| VEGA | Vega Bio Foods | 2026-03-06 | consumer_staples | $12.00 | $10.40 | $11.10 | -13.3% | +6.7% | -7.5% | -7.5% | $128M | 96.0% | 39.7% | 2026-09-02 | 66.8 | quote |
A blank return means the row has no first-trade or last price stored — it is not read as 0%.
Financial profile on the filings
Revenue, cash and debt columns as stored on the filing row, with the two derived screens the table keeps.
| Ticker | Revenue TTM | Growth | Net income | Gross margin | Debt | Cash | Burn /qtr | Runway | Altman Z | Debt/Rev |
|---|---|---|---|---|---|---|---|---|---|---|
| LUMN | $910M | 27.0% | $74.0M | 56.5% | $520M | $360M | $0.00 | cash-flow positive | 10.07 | 0.57× |
| LUMN | $910M | 27.0% | $74.0M | 56.5% | $520M | $360M | $0.00 | cash-flow positive | 10.07 | 0.57× |
| LUMN | $910M | 27.0% | $74.0M | 56.5% | $520M | $360M | $0.00 | cash-flow positive | 10.07 | 0.57× |
| LUMN | $910M | 27.0% | $74.0M | 56.5% | $520M | $360M | $0.00 | cash-flow positive | 10.07 | 0.57× |
| LUMN | $910M | 27.0% | $74.0M | 56.5% | $520M | $360M | $0.00 | cash-flow positive | 10.07 | 0.57× |
| NVX | $412M | 68.0% | $-12.0M | 65.3% | $214M | $120M | $3.00M | 40 mo | 9.24 | 0.52× |
| NVX | $412M | 68.0% | $-12.0M | 65.3% | $214M | $120M | $3.00M | 40 mo | 9.24 | 0.52× |
| NVX | $412M | 68.0% | $-12.0M | 65.3% | $214M | $120M | $3.00M | 40 mo | 9.24 | 0.52× |
| NVX | $412M | 68.0% | $-12.0M | 65.3% | $214M | $120M | $3.00M | 40 mo | 9.24 | 0.52× |
| NVX | $412M | 68.0% | $-12.0M | 65.3% | $214M | $120M | $3.00M | 40 mo | 9.24 | 0.52× |
| ATLS | $2.31B | 38.0% | $240M | 25.9% | $4.10B | $690M | $0.00 | cash-flow positive | 9.22 | 1.77× |
| ATLS | $2.31B | 38.0% | $240M | 25.9% | $4.10B | $690M | $0.00 | cash-flow positive | 9.22 | 1.77× |
| ATLS | $2.31B | 38.0% | $240M | 25.9% | $4.10B | $690M | $0.00 | cash-flow positive | 9.22 | 1.77× |
| ATLS | $2.31B | 38.0% | $240M | 25.9% | $4.10B | $690M | $0.00 | cash-flow positive | 9.22 | 1.77× |
| ATLS | $2.31B | 38.0% | $240M | 25.9% | $4.10B | $690M | $0.00 | cash-flow positive | 9.22 | 1.77× |
| HEAL | $0.00 | 0.0% | $-58.0M | 20.7% | $88.0M | $96.0M | $14.5M | 6 mo | 0.79 | not stored |
| HEAL | $0.00 | 0.0% | $-58.0M | 20.7% | $88.0M | $96.0M | $14.5M | 6 mo | 0.79 | not stored |
| HEAL | $0.00 | 0.0% | $-58.0M | 20.7% | $88.0M | $96.0M | $14.5M | 6 mo | 0.79 | not stored |
| HEAL | $0.00 | 0.0% | $-58.0M | 20.7% | $88.0M | $96.0M | $14.5M | 6 mo | 0.79 | not stored |
| HEAL | $0.00 | 0.0% | $-58.0M | 20.7% | $88.0M | $96.0M | $14.5M | 6 mo | 0.79 | not stored |
| FINO | $305M | 44.0% | $41.0M | 65.5% | $190M | $150M | $0.00 | cash-flow positive | -0.50 | 0.62× |
| FINO | $305M | 44.0% | $41.0M | 65.5% | $190M | $150M | $0.00 | cash-flow positive | -0.50 | 0.62× |
| FINO | $305M | 44.0% | $41.0M | 65.5% | $190M | $150M | $0.00 | cash-flow positive | -0.50 | 0.62× |
| FINO | $305M | 44.0% | $41.0M | 65.5% | $190M | $150M | $0.00 | cash-flow positive | -0.50 | 0.62× |
| FINO | $305M | 44.0% | $41.0M | 65.5% | $190M | $150M | $0.00 | cash-flow positive | -0.50 | 0.62× |
| GRID | $780M | 22.0% | $62.0M | 29.4% | $1.21B | $310M | $0.00 | cash-flow positive | 9.15 | 1.55× |
| GRID | $780M | 22.0% | $62.0M | 29.4% | $1.21B | $310M | $0.00 | cash-flow positive | 9.15 | 1.55× |
| GRID | $780M | 22.0% | $62.0M | 29.4% | $1.21B | $310M | $0.00 | cash-flow positive | 9.15 | 1.55× |
| GRID | $780M | 22.0% | $62.0M | 29.4% | $1.21B | $310M | $0.00 | cash-flow positive | 9.15 | 1.55× |
| GRID | $780M | 22.0% | $62.0M | 29.4% | $1.21B | $310M | $0.00 | cash-flow positive | 9.15 | 1.55× |
| ORBT | $1.42B | 31.0% | $96.0M | 69.5% | $640M | $410M | $0.00 | cash-flow positive | 8.31 | 0.45× |
| ORBT | $1.42B | 31.0% | $96.0M | 69.5% | $640M | $410M | $0.00 | cash-flow positive | 8.31 | 0.45× |
| ORBT | $1.42B | 31.0% | $96.0M | 69.5% | $640M | $410M | $0.00 | cash-flow positive | 8.31 | 0.45× |
| ORBT | $1.42B | 31.0% | $96.0M | 69.5% | $640M | $410M | $0.00 | cash-flow positive | 8.31 | 0.45× |
| ORBT | $1.42B | 31.0% | $96.0M | 69.5% | $640M | $410M | $0.00 | cash-flow positive | 8.31 | 0.45× |
| VEGA | $128M | 96.0% | $-19.0M | 54.1% | $96.0M | $210M | $4.75M | 44 mo | 1.02 | 0.75× |
| VEGA | $128M | 96.0% | $-19.0M | 54.1% | $96.0M | $210M | $4.75M | 44 mo | 1.02 | 0.75× |
| VEGA | $128M | 96.0% | $-19.0M | 54.1% | $96.0M | $210M | $4.75M | 44 mo | 1.02 | 0.75× |
| VEGA | $128M | 96.0% | $-19.0M | 54.1% | $96.0M | $210M | $4.75M | 44 mo | 1.02 | 0.75× |
| VEGA | $128M | 96.0% | $-19.0M | 54.1% | $96.0M | $210M | $4.75M | 44 mo | 1.02 | 0.75× |
Altman Z and debt/revenue are arithmetic on the stored columns; the filing itself may have published different figures.
How this page is populated
- Rows come from qm_ipo and qm_ipo_comparables. The demo set is flagged on each row's data_source.
- Prices for a listed ticker are the normal security rows — the quote column is last_price from that row, not a live quote.
- No filing here has been verified against a regulator's public documents, and none of this is investment advice or an indication of interest.
- The intel score and its breakdown are stored model outputs; open a filing to read the components and the risk flags.